Physician profile
Edwin A Amirata
NPI 1437227600
$3,841.06
in general payments reported to CMS, 2019-2025
27 companies · $920 in 2025
The $920 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $195 · 2021: $298 · 2022: $48.76 · 2023: $152 · 2024: $1,695 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,767.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,253.95 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Tela Bio, INC. | $601.32 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $508.17 | 2019-2020 | |
| Ethicon US, LLC | $377.81 | 2019-2025 | Megadyne, Echelon Endopath, Stratafix |
| Acera Surgical, INC. | $150.43 | 2023-2025 | Restrata Wound Matrix |
| Alexion Pharmaceuticals, INC. | $133.33 | 2021 | |
| Teleflex LLC | $128.94 | 2019-2025 | Deknatel, Titan Sgs Standard Gastric Stapler |
| Convatec INC. | $83.92 | 2024-2025 | |
| Conmed Corporation | $68.75 | 2024 | Airseal |
| Vertex Pharmaceuticals Incorporated | $63.80 | 2024-2025 | |
| Csl Behring | $55.21 | 2020-2022 | |
| Abbvie INC. | $50.98 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $48.20 | 2023 | Seglentis |
| Octapharma USA, INC. | $41.39 | 2025 | Fibryga |
| Innocoll Pharmaceuticals Limited | $37.39 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $35.38 | 2019-2021 | |
| Medtronic, INC. | $27.32 | 2025 | Maxtack |
| Solventum Corporation | $26.92 | 2025 | V.A.C.Ulta, V.A.C.Instill, Prevena |
| Integra Lifesciences Corporation | $24.21 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $19.80 | 2025 | General - Erectile Dysfunction |
| Mimedx Group, INC. | $17.22 | 2025 | |
| Smith+Nephew, INC. | $16.15 | 2024 | Collagenase Santyl |
| Avanos Medical | $14.92 | 2019 | |
| Heron Therapeutics, INC. | $14.66 | 2021 | |
| Mallinckrodt Enterprises LLC | $14.09 | 2019 | |
| Shire North American Group INC | $14.01 | 2019 | |
| Merck Sharp & Dohme LLC | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Amirata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.